Astex Pharmaceuticals
Generated by Meeveem AI
"Pioneering fragment based drug discovery to combat cancer and CNS disorders"
Cambridge
•51 - 250 Employees
•Biotechnology
About Astex Pharmaceuticals
Astex Pharmaceuticals pioneers fragment based drug discovery using its proprietary Pyramid platform to design innovative therapeutics for cancer and central nervous system disorders. Founded in 1999 in Cambridge, the company has built a robust pipeline spanning preclinical research through late stage clinical trials, with three drugs already approved and on the market. Operating as an independent subsidiary of Otsuka Pharmaceutical, Astex combines structural biology, AI driven chemistry, and quantum computing to tackle challenging disease targets. The company collaborates with leading pharmaceutical partners including Novartis, Janssen, and MSD, transforming scientific breakthroughs into treatments that improve patient outcomes.
240
Team Members
1999
Founded
Biotechnology
Sector
Hybrid
Work Environment
Our Vision
A world where cancer and central nervous system diseases are understood at the molecular level and defeated through precisely designed therapeutics that restore health and extend lives.
Our Mission
At Astex, our mission is to pioneer innovative drug discovery and development that addresses the extensive challenges in oncology and diseases of the central nervous system.